Posted on 2/3/21
Moleculin Prices Of $67.8 Million Underwritten Public Offering
Moleculin Biotech, Inc., (Nasdaq: MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced the . . .
Posted on 2/3/21
EQ Health Acquisition Corp. Closes of Upsized $220 Million IPO
AUSTIN, Texas--(BUSINESS WIRE)--EQ Health Acquisition Corp., today announced the closing of its upsized initial public offering of 21,999,960 units at a price of $10.00 per unit, . . .
Posted on 2/1/21
Mati Therapeutics Announces Purchase of Rights From Novelion Therapeutics
AUSTIN, Texas--(BUSINESS WIRE)--Mati Therapeutics Inc. announced that it has purchased all rights related to Mati’s Evolute Punctal Plug Delivery System (PPDS) from Novelion Therapeutics Inc. This purchase is . . .
Posted on 2/1/21
TechFW Client Nanoscope on Winning Team in National Eye Institute Challenge
With the eyes of the nation upon them, leading ophthalmic researchers at the University of Colorado, Miami University and those from Nanoscope® , led by Samarendra . . .
Posted on 1/29/21
Moleculin Announces Reverse Stock Split
Moleculin Biotech, Inc., (Nasdaq: MBRX), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that . . .
Posted on 1/29/21
EQ Health Acquisition Corp. Prices of Upsized $191.1 Million IPO
AUSTIN, Texas--(BUSINESS WIRE)--EQ Health Acquisition Corp., today announced the pricing of its initial public offering of 19,130,400 units at a price of $10.00 per unit. The . . .
Posted on 1/29/21
TechFW Client Nanoscope Receives 2nd Orphan Drug Designation from FDA
Nanoscope® Therapeutics Inc., a TechFW client, has received an Orphan drug designation from the U.S. Food and Drug Administration (FDA) for gene therapy-based treatment of Stargardt . . .
Posted on 1/28/21
QSAM Biosciences Closes Series B Preferred Private Placement
Austin, Texas, Jan. 28, 2021 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation nuclear medicines for the treatment of cancer and related . . .
Posted on 1/26/21
States that Have the Fewest COVID-19 Restrictions – Updated WalletHub Study
With the U.S. starting to open up more but a full reopening only possible once we achieve widespread vaccination, the personal-finance website WalletHub today released updated . . .
Posted on 1/21/21
Salarius Pharmaceuticals Regains Compliance with Nasdaq
HOUSTON, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid . . .
Posted on 1/14/21
KidsX Selects 13 Startups for Inaugural Cohort
LOS ANGELES--(BUSINESS WIRE)--KidsX, an international consortium of pediatric hospitals focused on improving digital health innovation through collaboration, has selected 13 startup companies to be part of . . .
Posted on 1/12/21
Latticework Capital Management Announces Investment in Beacon Behavioral Hospital
DALLAS--(BUSINESS WIRE)--Latticework Capital Management, a Dallas-based private equity firm focused on partnering with entrepreneurially-minded management teams to build leading healthcare companies, announced today that it has . . .
Posted on 12/22/20
Greenwich LifeSciences Closes of Public Offering of Common Stock
STAFFORD, Texas--(BUSINESS WIRE)--Greenwich LifeSciences, Inc. (Nasdaq: GLSI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients . . .
Posted on 12/18/20
Greenwich LifeSciences Prices $26.4 Million Upsized Public Offering of Common Stock
STAFFORD, Texas--(BUSINESS WIRE)--Greenwich LifeSciences, Inc. (Nasdaq: GLSI), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients . . .
Posted on 12/18/20
TPG and TA Associates Close on $1.6 Billion Planview Acquisition from Thoma Bravo
AUSTIN, Texas & SAN FRANCISCO & FORT WORTH, Texas & BOSTON--(BUSINESS WIRE)--TPG Capital, the private equity platform of global alternative asset firm TPG, and TA Associates, . . .
Posted on 12/14/20
Why Lexicon Pharmaceuticals Flopped on Friday
What happenedLexicon Pharmaceuticals (NASDAQ:LXRX) ended Friday 6% lower than the previous close. A fall seemed inevitable, as the company announced a rather dilutive new secondary common . . .
Posted on 12/11/20
Lexicon Announces Offers Common Stock
THE WOODLANDS, Texas, Dec. 11, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it had entered into a securities purchase agreement with . . .
Posted on 12/10/20
Tenet to Acquire Portfolio of Surgery Centers from SurgCenter Development
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) today announced that it will acquire a portfolio of up to 45 ambulatory surgery centers (ASCs) from SurgCenter Development (SCD). . . .
Posted on 12/10/20
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement
ENGLEWOOD, Colo. and GRAND PRAIRIE, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products . . .
Posted on 12/10/20
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
With frontline health care workers and other vulnerable populations like the elderly first in line to receive COVID-19 vaccinations, WalletHub today released its report on the . . .
Posted on 12/2/20
Reata Pharmaceuticals Prices of Class A Common Stock
PLANO, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced that it has priced a public offering . . .
Posted on 12/1/20
Reata Pharmaceuticals Proposes Public Offering of Class A Common Stock
PLANO, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA), a clinical-stage biopharmaceutical company, today announced the launch of a proposed underwritten public . . .
Posted on 11/23/20
Hospice Source Acquires Superior Healthcare
Hospice Source, a leading provider of durable medical equipment dedicated to the hospice market, acquired Superior Healthcare, Inc. of Martinez, California. The acquisition furthers Hospice Source's . . .
Posted on 11/13/20
Moleculin Biotech Reports Financial Results for the Quarter Ended September 30, 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and . . .
Posted on 11/13/20
Cassava Sciences Pricing of $75 Million Public Offering of Common Stock
AUSTIN, Texas, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, today announced the pricing of . . .
Houston
